<DOC>
	<DOCNO>NCT01938872</DOCNO>
	<brief_summary>evaluate effectiveness paclitaxel-eluting balloon below-the-knee angioplasty term restenosis 12 month</brief_summary>
	<brief_title>Evaluating Effectiveness Paclitaxel-eluting Balloons Below-the-knee Angioplasty Patients With Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>age &gt; 18 year angiographic stenosis &gt; 50 % occlusion one belowknee vessel allergy Paclitaxel contraindication combine antiplatelet treatment life expectancy &lt; 1 year hypersensitivity contraindication one study drug lack consent need amputation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>drug-eluting balloon</keyword>
	<keyword>restenosis</keyword>
</DOC>